Transaction DateRecipientSharesTypePriceValue
15th September 2020Erez Chimovits292,607Grant/award etc.$0.00
15th September 2020Erez Chimovits902,885Grant/award etc.$0.00
30th June 2020Israel Gp Ltd. Orbi Med6,786,500Conversion of derivative$0.00
19th December 2019Erez Chimovits3,500Open or private purchase$8.90$31,150.00
18th December 2019Erez Chimovits500Open or private purchase$8.93$4,465.00
11th December 2019Erez Chimovits5,400Open or private purchase$8.92$48,168.00
10th December 2019Erez Chimovits3,400Open or private purchase$8.75$29,750.00
9th December 2019Erez Chimovits6,000Open or private purchase$8.68$52,080.00
6th December 2019Erez Chimovits800Open or private purchase$8.00$6,400.00
5th December 2019Erez Chimovits3,400Open or private purchase$7.99$27,166.00
Novus Therapeutics
Novus Therapeutics logo

Novus Therapeutics Inc. engages in the acquisition, development, and commercialization of products for disorders of the ear, nose, and throat. The company's product pipelines include OPO201; OP0101; and OP0102.

Ticker: NVUS
Sector: Health Technology
Industry: Pharmaceuticals: Major
SEC Central Index Key (CIK): 1404281
Employees: 8
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals